2025-2031 Global Conbercept Industry Research & Trends Analysis Report- YH Research

日本语 | 中文

Home > Reports >Chemical & Material > 2025-2031 Global Conbercept Industry Research & Trends Analysis Report

2025-2031 Global Conbercept Industry Research & Trends Analysis Report

Publication Date: 2025-09-30
Report Id: 2489441
Industry: Chemical & Material
Report Page: 110
Chart: 120

PDF Download

Publication Date: 2025-09-30
Report Id: 2489441
Industry: Chemical & Material
Report Page: 110
Chart: 120

PDF Download

A research report provider that focuses on identifying industry pain points and solving core problems for companies！

Table of Contents
Description
Table of Figures
Need a Quote?

1 Market Overview
1.1 Conbercept Definition
1.2 Global Conbercept Market Size and Forecast
1.2.1 By Revenue, Global Conbercept Market Size, 2020-2031
1.2.2 By Sales Volume, Global Conbercept Market Size, 2020-2031
1.2.3 Global Conbercept Price Trend, 2020-2031
1.3 China Conbercept Market Size and Forecast
1.3.1 By Revenue, China Conbercept Market Size, 2020-2031
1.3.2 By Sales Volume, China Conbercept Market Size, 2020-2031
1.3.3 China Conbercept Price Trend, 2020-2031
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Conbercept Share in Global Market, 2020-2031
1.4.2 By Sales Volume, China Conbercept Share in Global Market, 2020-2031
1.4.3 Conbercept Market Size: China VS Global, 2020-2031
1.5 Conbercept Market Dynamics
1.5.1 Conbercept Market Drivers
1.5.2 Conbercept Market Restraints
1.5.3 Conbercept Industry Trends
1.5.4 Conbercept Industry Policy

2 Global Competitive Landscape by Company
2.1 Global Conbercept Revenue by Company, 2020-2025
2.2 Global Conbercept Sales Volume by Company, 2020-2025
2.3 Global Conbercept Price by Company, 2020-2025
2.4 Global Conbercept Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Conbercept Concentration Ratio
2.6 Global Conbercept Mergers & Acquisitions, Expansion Plans
2.7 Global Conbercept Manufacturers Product Type

3 China Competitive Landscape by Company
3.1 China Conbercept Revenue by Company, 2020-2025
3.2 China Conbercept Sales Volume by Company, 2020-2025
3.3 China Conbercept Conbercept Participants, Market Position (Tier 1, Tier 2, and Tier 3)
3.4 China Conbercept Market, Sales Percentage of Local Players VS Foreign Players (2020-2025)
3.5 Chinese Local Players, Conbercept Domestic VS Export
3.6 China Market, Conbercept Import & Export
3.6.1 China Market, Conbercept Import & Export, 2020-2031
3.6.2 China Conbercept Import & Export Trends
3.6.3 Main Sources of China Conbercept Import
3.6.4 Export Destination of China Conbercept

4 Conbercept Production by Region
4.1 Global Conbercept Capacity, Production and Capacity Utilization, 2020-2031
4.2 Global Geographic Distribution of Conbercept Manufacturers
4.3 Global Major Manufacturers, Conbercept Capacity Expansion and Future Plans
4.4 Global Conbercept Capacity by Region
4.5 Global Conbercept Production by Region
4.5.1 Global Conbercept Production & Forecast by Region, 2020 VS 2024 VS 2031
4.5.2 Global Conbercept Production by Region, 2020-2025
4.5.3 Global Conbercept Production Market Share & Forecast by Region, 2020-2031

5 Industry Chain Analysis
5.1 Conbercept Industry Chain
5.2 Conbercept Upstream Analysis
5.2.1 Conbercept Core Raw Materials
5.2.2 Main Manufacturers of Conbercept Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Conbercept Production Mode
5.6 Conbercept Procurement Model
5.7 Conbercept Industry Sales Model and Sales Channels
5.7.1 Conbercept Sales Model
5.7.2 Conbercept Typical Distributors

6 Sights by Product Type
6.1 Conbercept Classification
6.1.1 API
6.1.2 Preperation
6.2 by Type, Global Conbercept Market Size & CAGR, 2020 VS 2024 VS 2031
6.3 by Type, Global Conbercept Revenue, 2020-2031
6.4 by Type, Global Conbercept Sales Volume, 2020-2031
6.5 by Type, Global Conbercept Price, 2020-2031

7 Sights by Application
7.1 Conbercept Segment by Application
7.1.1 nAMD
7.1.2 pmCNV
7.1.3 DME
7.2 by Application, Global Conbercept Market Size & CAGR, 2020 VS 2024 VS 2031
7.3 by Application, Global Conbercept Revenue, 2020-2031
7.4 by Application, Global Conbercept Sales Volume, 2020-2031
7.5 by Application, Global Conbercept Price, 2020-2031

8 Sales Sights by Region
8.1 By Region, Global Conbercept Market Size, 2020 VS 2024 VS 2031
8.2 By Region, Global Conbercept Revenue, 2020-2031
8.3 By Region, Global Conbercept Sales Volume, 2020-2031
8.4 North America
8.4.1 North America Conbercept Market Size & Forecasts, 2020-2031
8.4.2 By Country, North America Conbercept Market Size Market Share
8.5 Europe
8.5.1 Europe Conbercept Market Size & Forecasts, 2020-2031
8.5.2 By Country, Europe Conbercept Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Conbercept Market Size & Forecasts, 2020-2031
8.6.2 By Country/Region, Asia Pacific Conbercept Market Size Market Share
8.7 South America
8.7.1 South AmericaConbercept Market Size & Forecasts, 2020-2031
8.7.2 By Country, South America Conbercept Market Size Market Share
8.8 Middle East & Africa

9 Sales Sights by Country Level
9.1 By Country, Global Conbercept Market Size & CAGR，2020 VS 2024 VS 2031
9.2 By Country, Global Conbercept Revenue, 2020-2031
9.3 By Country, Global Conbercept Sales Volume, 2020-2031
9.4 United States
9.4.1 United States Conbercept Market Size, 2020-2031
9.4.2 By Company, United States Conbercept Sales Volume Market Share, 2024
9.4.3 by Type, United States Conbercept Market Size, Share, 2024 VS 2031
9.4.4 by Application, United States Conbercept Market Size, Share, 2024 VS 2031
9.5 Europe
9.5.1 Europe Conbercept Market Size, 2020-2031
9.5.2 By Company, Europe Conbercept Sales Volume Market Share, 2024
9.5.3 by Type, Europe Conbercept Market Size, Share, 2024 VS 2031
9.5.4 by Application, Europe Conbercept Market Size, Share, 2024 VS 2031
9.6 China
9.6.1 China Conbercept Market Size, 2020-2031
9.6.2 By Company, China Conbercept Sales Volume Market Share, 2024
9.6.3 by Type, China Conbercept Market Size, Share, 2024 VS 2031
9.6.4 by Application, China Conbercept Market Size, Share, 2024 VS 2031
9.7 Japan
9.7.1 Japan Conbercept Market Size, 2020-2031
9.7.2 By Company, Japan Conbercept Market Share, 2024
9.7.3 by Type, Japan Conbercept Market Size, Share, 2024 VS 2031
9.7.4 by Application, Japan Conbercept Market Size, Share, 2024 VS 2031
9.8 South Korea
9.8.1 South Korea Conbercept Market Size, 2020-2031
9.8.2 By Company, South Korea Conbercept Market Share, 2024
9.8.3 by Type, South Korea Conbercept Market Size, Share, 2024 VS 2031
9.8.4 by Application, South Korea Conbercept Market Size, Share, 2024 VS 2031
9.9 Southeast Asia
9.9.1 Southeast Asia Conbercept Market Size, 2020-2031
9.9.2 By Company, Southeast Asia Conbercept Market Share, 2024
9.9.3 by Type, Southeast Asia Conbercept Market Size, Share, 2024 VS 2031
9.9.4 by Application, Southeast Asia Conbercept Market Size, Share, 2024 VS 2031
9.10 India
9.10.1 India Conbercept Market Size, 2020-2031
9.10.2 By Company, India Conbercept Market Share, 2024
9.10.3 by Type, India Conbercept Market Size, Share, 2024 VS 2031
9.10.4 by Application, India Conbercept Market Size, Share, 2024 VS 2031
9.11 Middle East & Africa
9.11.1 Middle East & Africa Conbercept Market Size, 2020-2031
9.11.2 By Company, Middle East & Africa Conbercept Market Share, 2024
9.11.3 by Type, Middle East & Africa Conbercept Market Size, Share, 2024 VS 2031
9.11.4 by Application, Middle East & Africa Conbercept Market Size, Share, 2024 VS 2031

10 Manufacturers Profile
10.1 Kanghong Pharmaceutical
10.1.1 Kanghong Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.1.2 Kanghong Pharmaceutical Conbercept Models, Specifications, and Application
10.1.3 Kanghong Pharmaceutical Conbercept Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.1.4 Kanghong Pharmaceutical Company Profile and Main Business
10.1.5 Kanghong Pharmaceutical Recent Developments

11 Conclusion

12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer

According to YH Research, the global market for Conbercept should grow from US$ 193 million in 2024 to US$ 327 million by 2031, with a CAGR of 7.8% for the period of 2025-2031.

The strategic recalibration of 2025 U.S. tariff mechanisms is redefining global economic governance norms. This study deciphers the transmission mechanisms of tariff escalation pathways and global policy responses on corporate investment strategies, regional trade networks, and critical material supply architectures.

Conbercept

According to YH Research, the global market for Conbercept should grow from US$ 193 million in 2024 to US$ 327 million by 2031, with a CAGR of 7.8% for the period of 2025-2031.

Unit: US$ M

www.yhresearch.com

In-depth insight into market trends

Conbercept is a recombinant fusion protein used as an anti-angiogenic agent. It is primarily employed in the treatment of various eye conditions, including neovascular (wet) age-related macular degeneration (AMD), diabetic macular edema (DME), and other retinal vascular diseases. Conbercept works by inhibiting the formation of new blood vessels, which is a key factor in the progression of certain eye diseases.

Key Points about Conbercept:
Mechanism of Action: Conbercept is designed to block the activity of vascular endothelial growth factor (VEGF), a protein that plays a crucial role in the development of abnormal blood vessels in the retina. By inhibiting VEGF, Conbercept helps reduce the growth of these abnormal blood vessels.

Administration: Conbercept is typically administered through intravitreal injection, meaning it is injected directly into the eye.

Approved Indications: Conbercept has received regulatory approval in some countries for the treatment of neovascular age-related macular degeneration (nAMD), diabetic macular edema (DME), and other retinal vascular diseases.

Manufacturer: Conbercept is produced by Chengdu Kanghong Biotech Co., Ltd., a biopharmaceutical company based in China.

Growing Incidence of Retinal Diseases: The prevalence of retinal diseases, such as age-related macular degeneration and diabetic retinopathy, has been increasing globally. This trend has driven the demand for effective treatments like Conbercept.

Expansion of Market Access: Conbercept has gained regulatory approval in several countries, contributing to its market expansion. The availability of Conbercept for patients in different regions has likely influenced market trends.

Competition in the Anti-VEGF Market: The market for anti-VEGF drugs, including Conbercept, is competitive. Other drugs in this class, such as ranibizumab and aflibercept, also play a significant role in the management of retinal diseases.

Research and Development: Ongoing research and development efforts in the field of ophthalmology may lead to the introduction of new therapies or improvements in existing treatments, impacting the market dynamics for Conbercept.

Healthcare Infrastructure and Reimbursement Policies: The accessibility of Conbercept and other similar drugs can be influenced by factors such as healthcare infrastructure, reimbursement policies, and economic considerations in different regions.

This report aims to provide a comprehensive study of the global market for Conbercept.
Report Highlights:
(1) Global Conbercept market size (sales volume & revenue), history data from 2020-2025, and forecast data from 2026 to 2031.

(2) Global Conbercept market competitive situation, sales, revenue, price, and market share, from 2020 to 2025.

(3) China Conbercept market competitive situation, sales, revenue, price, and market share, from 2020 to 2025.

(4) Global Conbercept segment by region (or country), key regions cover the United States, Europe, China, Japan, South Korea, Southeast Asia, and India, etc.

(5) Global Conbercept segment by Type, and by Application, and regional segment by Type, and by Application.

(6) Global major production regions of Conbercept, capacity, production and trends.

(7) Conbercept industry supply chain, upstream, midstream, and downstream analysis.

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by Type, covers
API
Preperation

Market segment by Application, can be divided into
nAMD
pmCNV
DME

Market segment by players, this report covers
Kanghong Pharmaceutical